Home
Clinical Trials
e-NOBORI Observational Regist...

e-NOBORI Observational Registry of Nobori DES

Last Updated: 2019-10-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

18000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-25

Study Completion Date

2016-05-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Title Prospective, single-arm, multi-centre, observational registry to further validate safety and efficacy of the Nobori® DES in real-world patients.

Objective Primary objective The primary objective of e-NOBORI registry is to further validate the safety and efficacy of Nobori® DES system in unselected patients representing everyday clinical practice.

Primary Endpoint: Freedom from Target Lesion Failure (TLF) defined as a composite of cardiac death, target vessel related myocardial infarction (MI) and clinically driven target lesion revascularization (TLR) at 1 year

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ANGiographic Evaluation of Left Main Coronary Artery INtErvention

NCT04604197

Coronary Occlusion Left Main Coronary Artery Disease Coronary Artery Stenosis +2 more

ACTIVE_NOT_RECRUITING NA

Imaging and Biomarkers of Atherosclerosis in Patients With Stable or Unstable Coronary Artery Disease

NCT01186666

Atherosclerosis Coronary Artery Disease Acute Coronary Syndrome

COMPLETED NA

Registry of Secondary Revascularization

NCT03349385

Coronary Artery Disease Progression Coronary Artery Disease of Significant Bypass Graft Stent Stenosis +2 more

ACTIVE_NOT_RECRUITING

Efficacy and Safety of GENOSS® DES in Patients with Coronary Artery Disease

NCT06066476

Coronary Artery Disease

COMPLETED

The Influence of Modifying Highly Calcified Coronary Lesions on Coronary Microcirculation

NCT06507449

Coronary Artery Calcification Ischemic Heart Disease Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) +3 more

ENROLLING_BY_INVITATION NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Title Prospective, single-arm, multi-centre, observational registry to further validate safety and efficacy of the Nobori® DES in real-world patients.
* Primary objective The primary objective of e-NOBORI registry is to further validate the safety and efficacy of Nobori® DES system in unselected patients representing everyday clinical practice.
* Primary Endpoint: Freedom from Target Lesion Failure (TLF) defined as a composite of cardiac death, target vessel related myocardial infarction (MI) and clinically driven target lesion revascularization (TLR) at 1 year
* Clinical Site Locations:

Up to 200 centres across Europe, Asia and Central and South America

-Patient Population : \~18000 eligible patients suitable for treatment with the Nobori® DES will be entered in the e-NOBORI registry

Eligibility Criteria

* Patient is more or equal 18 years old;
* Patient is, according to hospital routine practice, eligible for percutaneous coronary intervention using DES (and RVD matches available Nobori® DES sizes);
* Patient has been informed of the nature of the study and agrees to its provisions, has provided written informed consent as approved by the Institutional Review Board/Ethics Committee of the respective clinical site, wherever such requirement exists.

NOTE: In order to avoid bias it is recommended that all investigators aim to enrol all consecutive patients complying with study eligibility criteria. It is also desirable to have at least two cardiologists as investigators in each centre.

According to pre-specified criteria, patients will be automatically allocated to one or more sub-studies as following:

* NOBORI Acute Coronary Syndrome
* NOBORI Stable angina
* NOBORI Female
* NOBORI Bifurcation
* NOBORI Diabetes

* Insulin Dependent Diabetes Mellitus (IDDM)
* Non-Insulin Dependent Diabetes Mellitus (NIDDM)
* NOBORI Small Vessels (less or equal 2.75mm)
* NOBORI Long Lesions (more or equal 20mm)
* NOBORI Renal Insufficiency (\> 2.0 mg/dL - 176 µmol/mL)
* NOBORI Elderly (more or equal 80 years of age)
* NOBORI Restenosis
* NOBORI Multivessel Treatment
* NOBORI Complex Lesions

In addition to above mentioned sub-studies there will be geographic sub-studies for the main areas.

Medication Pre-Procedure: According to hospital routine practice Post-Procedure: Mandatory antiplatelet treatment, according to hospital routine practice (minimum 6 months DAT)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.